Solutions: Using an innovative method to predict creep performance, the polymer’s viscoelastic properties were characterized under conditions that simulated use in the human body over a 20-year span. Solutions: Using an innovative method to predict creep performance, the polymer’s viscoelastic properties were characterized under conditions that simulated use in the human body over a 20-year span.

Expand EBITDA margins to 20% 3. AS HIS H KHANDP UR P R E S I D E N T & C E O 7 8 PORTFOLIO TRANSFORMATION 8 7% 46% 66% 87% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2015 2020 2023 % o f A dj us te d E B IT D A Commodity JVs Distribution Performance Products & Solutions Specialty Businesses Adjusted EBITDA from Specialty Applications SUSTAINABILITY AS A GROWTH DRIVER 9 LONG-TERM REVENUE GROWTH DRIVERS Sustainable Solutions Composites, Healthcare, Asia / LATAM Overlap Other 60%+ Key Growth Drivers Total Company Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Composites 8–10% Healthcare 8–10% Asia / LATAM 5% Other 0–2% Avient 6% END MARKET OBSERVATIONS ( % O F C O M PA N Y S A L E S ) ENERGY 5% DEFENSE 7% TELECOMMUNICATIONS 4% HEALTHCARE 7% 10 TRANSPORTATION 10% INDUSTRIAL 16% BUILDING & CONSTRUCTION 9% CONSUMER 19% PACKAGING 23% 11 REGIONAL OBSERVATIONS ( % O F C O M PA N Y S A L E S ) 11 US & Canada Latin America EMEA Asia 41% 36% 18% 5% Q 4 2 0 2 3 R E S U L T S Q4 2023 PERFORMANCE VS. Free Cash Flow Calculation December 31, 2023 Cash provided by operating activities $ 201.6 Taxes paid on gain on sale of business 104.1 Adjusted cash provided by operating activities $ 305.7 Capital expenditures $ (119.4) Free cash flow $ 186.3 2 Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Sales: Color, Additives and Inks $ 459.4 $ 490.8 $ 2,007.4 $ 2,355.0 Specialty Engineered Materials 259.8 300.8 1,138.2 1,044.4 Corporate (0.2) (1.2) (2.8) (2.5) Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Operating income: Color, Additives and Inks $ 61.8 $ 44.3 $ 259.9 $ 301.0 Specialty Engineered Materials 29.4 35.2 142.5 140.1 Corporate (48.1) (79.1) (205.6) (197.8) Operating income $ 43.1 $ 0.4 $ 196.8 $ 243.3 Other expense, net: $ 4.3 $ (28.4) $ 5.8 $ (59.7) Depreciation & amortization: Color, Additives and Inks $ 22.2 $ 25.2 $ 98.3 $ 101.3 Specialty Engineered Materials 19.8 20.3 81.5 48.7 Corporate 2.2 3.1 9.0 12.5 Depreciation & amortization $ 44.2 $ 48.6 $ 188.8 $ 162.5 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 84.0 $ 69.5 $ 358.2 $ 402.3 Specialty Engineered Materials 49.2 55.5 224.0 188.8 Corporate (45.9) (76.0) (196.6) (185.3) Other expense, net $ 4.3 $ (28.4) $ 5.8 $ (59.7) EBITDA $ 91.6 $ 20.6 $ 391.4 $ 346.1 Special items in EBITDA 22.3 86.8 110.4 162.5 EBITDA - excluding special items $ 113.9 $ 107.4 $ 501.8 $ 508.6 APM pro forma adjustments - 8 months 2022* — — — 83.1 Pro forma EBITDA $ 113.9 $ 107.4 $ 501.8 $ 591.7 * Pro forma adjustment for January - August 2022 APM results (period before Avient ownership). 3 AVNT February IR Presentation_w_Non-GAAP Recs.pdf AVNT February IR Presentation.pdf Avient corporation�investor presentation DISCLAIMER Slide Number 3 Creating a world-class�sustainable organization Top-tier sustainability performance�and recognition Slide Number 6 Slide Number 7 Portfolio transformation Slide Number 9 END MARKET observations�(% of company sales) Regional observations�(% of company sales) Slide Number 12 Slide Number 13 Slide Number 14 Slide Number 15 Slide Number 16 Slide Number 17 Slide Number 18 Slide Number 19 Slide Number 20 Slide Number 21 Slide Number 22 2023 segment, end market and Geography Color, Additives & Inks Specialty Engineered Materials Slide Number 26 AVNT Q4 2023 Earnings Presentation.pdf AVNT Q4 2023 Earnings Presentation_For Website_with Non-GAAP.pdf IR Deck - AVNT-2023.12.31 (2.12.24 9PM Milestone February 12 0905 pm).pdf Attachment 3.26.24 - Public Lender Presentation Non-GAAP Attachments (005).pdf

Knowsley, United Kingdom 20. Heerlen, Netherlands 20. PREETE Director February 20, 2024 Kerry J.

KEY PERFORMANCE PROPERTIES1 PHYSICAL NOMINAL VALUE UNIT TEST METHOD Density/Specific Gravity 1.00 ASTM D792 Melt Mass-Flow Rate (MFR) (230°C/2.16kg) 20 g/10 min ASTM D1238 MECHANICAL Tensile Strength 15.0 MPa ASTM D638 Flexural Modulus 1400 MPa ASTM D790 Flexural Strength 35.0 MPa ASTM D790 IMPACT Notched Izod Impact (Injection Molded) 150 J/m ASTM D256 ELECTRICAL Surface Resistivity < 100000 ohms/sq ASTM D257 PROCESSING INFORMATION INJECTION NOMINAL VALUE UNIT Drying Temperature 80 to 90 °C Drying Time 4.0 to 6.0 hr Processing (Melt) Temperature 220 to 250 °C Mold Temperature 30 to 80 °C Trilliant™ HC Electrically Conductive Formulations for Precision Performance Pipette Tips A critical design consideration for pipette tips is the accurate measurement of finite amounts of liquid.

Wavelength (nm) – C93 Control 5 – Ultimate UV390-1 @ 0.15% 1 – UV390R 3 90 80 70 60 50 40 30 20 10 0 300 350 400 450 500 550 600 650 700 Tr an sm is si on (% ) 1.844.4AVIENT www.avient.com Copyright © 2023, Avient Corporation.

650.00 Black 10% 433C 650.01 Brown 10% 7615C 650.02 Red 10% 186C 650.03 Orange 5% 1495C 650.04 Yellow 10% 142C 650.05 Green 10% 2248C 650.06 Blue 10% 278C 650.07 Violet 20% 2073C 650.08 Grey 10% Cool Gray 7C 650.09 White 10% RAL9010 PPSU RESINS Product Code Color LDR* Pantone No.** 660.00 Black 6% Black 6C 660.01 Brown 6% 7582C 660.02 Red 8% 7620C 660.03 Orange 6% 1505C 660.04 Yellow 6% 124C 660.05 Green 6% 348C 660.06 Blue 6% 660C 660.07 Violet 15% 7664C 660.08 Grey 6% Cool Gray 8C 660.09 White 6% RAL9010 PSU RESINS Product Code Color RAL No.* S837.0 Black 9005 S837.1 Brown 8011 S837.2 Red 3002 S837.3 Orange 2004 S837.4 Light Yellow 1016 S837.5 Green 6032 S837.6 Blue 5015 S837.7 Violet 4005 S837.8 Grey 7037 S837.9 White 9016 PES RESINS Copyright © 2021, Avient Corporation.

WIRE HARNESS YARN FIBERS PROCESS PRODUCTS Product ID FIBER-LINE® Coating Base Fiber Break Strength Yield Geometry Nominal Diameter Description NX1200T FIBER-LINE® WearcoatTM FIBER-LINE® ColorcoatTM Nomex 13 LBs (5.9 KGs) 9930 FT/LB (6672 M/KG) Round/Flat .438mm High-temperature resistant coating with colorant for identification K400T FIBER-LINE® WearcoatTM Kevlar® 20 LBs (9.1 KGs) 30303 FT/LB (20362 M/KG) Round/Flat .245mm High-temperature resistant coating NX1200 1x3 FIBER-LINE® ColorcoatTM Nomex 39.9 LBs (18.1 KGs) 3225 FT/LB (2167 M/KG) Round .815mm Color coated for identification G150 1x3 FIBER-LINE® WearcoatTM Glass 16.7 LBs (7.6 KGs) 12987 FT/LB (8726 M/KG) Round .372mm High-temperature resistant coating NX200T N/A Nomex 2.5 LBs (1.1 KGs) 68166 FT/LB (45804 M/KG) Round/Flat .168mm Fiber twisted to improve handling MOVING HIGH PERFORMANCE FIBERS FORWARD This data is provided for informational purposes only, and does not constitute a specification.

Page 93 2011 Highlights • Versus 2010, revenue growth of 9% drives 23% increase in adjusted operating income • Adjusted EPS expands 29% to all-time high of $1.02 Net Sales Adjusted Operating $1.02 Adjusted EPS $2,622 $2,643 $2,739 $2,061 $2,622 $2,864 Net Sales $88 $87 $72 $59 $147 $181 Adjusted Operating Income $0.12 $0.27 $0.21 $0.13 $0.79 $1.02 ($ millions) ($ millions) Page 94 2011 Highlights • Each platform contributed to our year over year operating income growth • Record OI achieved in Specialty and POD • Ten quarters of double-digit adjusted EPS expansion POD PP&SSpecialty Platform ROS%* 0.6% 1.5% 3.2% 4.3% 5.3% 8.4% 8.0% 2.9% 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% 6.7% 5.5% 6.1% 3.1% 5.0% 7.0% 7.2% $20 $19 $22 $28 $25 $42 $56 O p e ra ti n g I n c o m e POD $76 $64 $66 $31 $33 $54 $62 O p e ra ti n g In c o m e PP&S $5 $13 $31 $46 $46 $87 $89 O p e ra ti n g I n c o m e Specialty Platform *ROS% is defined as adjusted operating income % of revenue ($ millions) Page 95 2011 Highlights • Continued portfolio repositioning � Sale of SunBelt equity investment � Acquisition of specialty companies ColorMatrix and Uniplen • World-class working capital of 9.6% maintained while improving on-time delivery to 94%improving on-time delivery to 94% 81% 87% 88% 95% 93% 92% 94% 2005 2006 2007 2008 2009 2010 2011 14.3% 16.2% 14.4% 18.9% 11.7% 9.6% 9.6% 2005 2006 2007 2008 2009 2010 2011 On-Time Delivery Working Capital % of Sales Page 96 First Quarter 2012 Highlights • Revenues increased 9% over Q1 2011 to a new quarterly record • Adjusted EPS increased 12% $0.26 $0.29 Q1 2011 Q1 2012 Adjusted EPS • Adjusted EPS increased 12% over prior year • All platforms delivered double-digit operating income growth Q1 2011 Q1 2012 $25.2 $14.7 $29.1 $17.8 $16.7 Specialty PP&S POD Q1 2011 Q1 2012 Adjusted Operating Income $14.3 ($ millions) Page 97 • Total Debt at 3/31/12 Less: Cash Net Debt • Available Liquidity $706 186 $520 $300 $360 $250 $300 $350 $400 $450 Debt Maturities As of March 31, 2012 ($ millions) Debt Maturities & Liquidity Summary – 3/31/12 • Available Liquidity Cash ABL Availability Total Liquidity • Net Debt / EBITDA* = 1.9x $186 156 $342 *Adjusted EBITDA TTM Pro forma for ColorMatrix $50 $300 $0 $50 $100 $150 $200 $250 2015 2017 2020 Page 98 • Repurchased 6 million shares in 2011 Share Share RepurchaseRepurchase • Introduced a quarterly dividend in Q1 2011 and increased in Q1 DividendsDividends • Expanding our sales, marketing, and technical capabilities is top Organic Organic GrowthGrowth • Targets that expand our: • Specialty offering • End market presence AcquisitionsAcquisitions Use of Cash Current Cash Balance = $186M Net Debt / EBITDA* = 1.9X • 7.9 million shares remain available for repurchase under the current authorization increased in Q1 2012 • Objective of maintaining and growing capabilities is top priority • Investing in operational and LSS initiatives • CAPEX • End market presence • Geographic footprint • Synergy opportunities • Adjacent material solutions *Adjusted EBITDA TTM Pro forma for ColorMatrix Page 99 Page 100

Finally, by promoting the more environmentally conscious new non-halogenated products, Schneider-Electric NB (Strömfors) may be able to increase its market share by approximately 20%.

Public Health Service, the incidence of hospital-acquired infections (HAI’s), such as MRSA and VRE, has increased approximately 36% in the last 20 years and today causes nearly 100,000 deaths annually.